Document Detail


Diets with high or low protein content and glycemic index for weight-loss maintenance.
MedLine Citation:
PMID:  21105792     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Studies of weight-control diets that are high in protein or low in glycemic index have reached varied conclusions, probably owing to the fact that the studies had insufficient power.
METHODS: We enrolled overweight adults from eight European countries who had lost at least 8% of their initial body weight with a 3.3-MJ (800-kcal) low-calorie diet. Participants were randomly assigned, in a two-by-two factorial design, to one of five ad libitum diets to prevent weight regain over a 26-week period: a low-protein and low-glycemic-index diet, a low-protein and high-glycemic-index diet, a high-protein and low-glycemic-index diet, a high-protein and high-glycemic-index diet, or a control diet.
RESULTS: A total of 1209 adults were screened (mean age, 41 years; body-mass index [the weight in kilograms divided by the square of the height in meters], 34), of whom 938 entered the low-calorie-diet phase of the study. A total of 773 participants who completed that phase were randomly assigned to one of the five maintenance diets; 548 completed the intervention (71%). Fewer participants in the high-protein and the low-glycemic-index groups than in the low-protein-high-glycemic-index group dropped out of the study (26.4% and 25.6%, respectively, vs. 37.4%; P=0.02 and P=0.01 for the respective comparisons). The mean initial weight loss with the low-calorie diet was 11.0 kg. In the analysis of participants who completed the study, only the low-protein-high-glycemic-index diet was associated with subsequent significant weight regain (1.67 kg; 95% confidence interval [CI], 0.48 to 2.87). In an intention-to-treat analysis, the weight regain was 0.93 kg less (95% CI, 0.31 to 1.55) in the groups assigned to a high-protein diet than in those assigned to a low-protein diet (P=0.003) and 0.95 kg less (95% CI, 0.33 to 1.57) in the groups assigned to a low-glycemic-index diet than in those assigned to a high-glycemic-index diet (P=0.003). The analysis involving participants who completed the intervention produced similar results. The groups did not differ significantly with respect to diet-related adverse events.
CONCLUSIONS: In this large European study, a modest increase in protein content and a modest reduction in the glycemic index led to an improvement in study completion and maintenance of weight loss. (Funded by the European Commission; ClinicalTrials.gov number, NCT00390637.).
Authors:
Thomas Meinert Larsen; Stine-Mathilde Dalskov; Marleen van Baak; Susan A Jebb; Angeliki Papadaki; Andreas F H Pfeiffer; J Alfredo Martinez; Teodora Handjieva-Darlenska; Marie Kunešová; Mats Pihlsgård; Steen Stender; Claus Holst; Wim H M Saris; Arne Astrup;
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The New England journal of medicine     Volume:  363     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-25     Completed Date:  2010-12-02     Revised Date:  2011-09-06    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2102-13     Citation Subset:  AIM; IM    
Affiliation:
Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Copenhagen, Denmark. tml@life.ku.dk
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00390637
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abdominal Pain / etiology
Adult
Biological Markers / urine
Body Mass Index
Diet, Carbohydrate-Restricted
Diet, Protein-Restricted* / adverse effects
Diet, Reducing*
Dietary Proteins / administration & dosage*
Glycemic Index*
Humans
Intention to Treat Analysis
Obesity / diet therapy
Overweight / diet therapy*
Patient Compliance
Weight Loss
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Dietary Proteins
Comments/Corrections
Comment In:
N Engl J Med. 2010 Nov 25;363(22):2159-61   [PMID:  21105799 ]
N Engl J Med. 2011 Feb 24;364(8):779-80; author reply 780-1   [PMID:  21345116 ]
N Engl J Med. 2011 Feb 24;364(8):779; author reply 780-1   [PMID:  21345117 ]
N Engl J Med. 2011 Feb 24;364(8):780; author reply 780-1   [PMID:  21345115 ]
Evid Based Med. 2011 Aug;16(4):112-3   [PMID:  21386115 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reduced mortality after allogeneic hematopoietic-cell transplantation.
Next Document:  Use of proton-pump inhibitors in early pregnancy and the risk of birth defects.